Additionally, in conjunction with prior studies identifying conformational CYP2E1 epitopes (16), our identification of MHC-restricted CYP2E1 epitopes can be utilized to develop specific diagnostic tests for drug-induced or viral hepatitis or associated fibrosis or to predict individuals at risk for developing these diseases or their sequelae. This evidence concerns the gene CYP2E1 and animal viral hepatitis.